1201965

John A. Phillips, III M.D. — FEI 3015945595

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional Details

Clinical Investigator (CI)